Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00009815 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | University of PittsburghOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00009828 | Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | University of PittsburghOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT01437280 |
| GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers(GOAT) |
| withdrawn |
| Phase 1 |
| 0 |
| Baylor College of MedicineOTHER |
| 0 |
| Aug 14, 2013 |
| clinicaltrials |
| NCT00017537 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Aug 5, 2013 | clinicaltrials |
| NCT00072228 | Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors | withdrawn | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00499668 | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer | withdrawn | N/A | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT01007422 | Opioids Titration in Hospice Patients | withdrawn | — | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT01568632 | Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Nov 21, 2012 | clinicaltrials |
| NCT01521299 | A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors | withdrawn | Phase 1 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Aug 28, 2012 | clinicaltrials |
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003985 | KRN7000 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00886496 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00415376 | Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT00442741 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | withdrawn | Phase 1 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 25, 2012 | clinicaltrials |
| NCT00402935 | Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00737191 | Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain | withdrawn | N/A | 0 | Mayo ClinicOTHER | 0 | Mar 9, 2012 | clinicaltrials |
| NCT01194193 | Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours | withdrawn | Phase 1 | 63 | AstraZenecaINDUSTRY | 0 | May 16, 2011 | clinicaltrials |
| NCT00159016 | Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. | withdrawn | Phase 2 | 100 | Hadassah Medical OrganizationOTHER | 1 | Apr 28, 2011 | clinicaltrials |
| NCT00148993 | Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors | withdrawn | Phase 1 / Phase 2 | 100 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00149019 | Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies. | withdrawn | Phase 2 | 12 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00754104 | Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors | withdrawn | Phase 1 | 0 | AbbottINDUSTRY | 0 | Jan 19, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Dec 19, 2013source: clinicaltrials